Craggs Peter D, Mouilleron Stephane, Rejzek Martin, de Chiara Cesira, Young Robert J, Field Robert A, Argyrou Argyrides, de Carvalho Luiz Pedro S
Platform Technology and Science , GlaxoSmithKline , Stevenage , U.K.
John Innes Centre , Norwich , U.K.
Biochemistry. 2018 Jun 19;57(24):3387-3401. doi: 10.1021/acs.biochem.8b00121. Epub 2018 May 2.
The biosynthetic pathway of peptidoglycan is essential for Mycobacterium tuberculosis. We report here the acetyltransferase substrate specificity and catalytic mechanism of the bifunctional N-acetyltransferase/uridylyltransferase from M. tuberculosis (GlmU). This enzyme is responsible for the final two steps of the synthesis of UDP- N-acetylglucosamine, which is an essential precursor of peptidoglycan, from glucosamine 1-phosphate, acetyl-coenzyme A, and uridine 5'-triphosphate. GlmU utilizes ternary complex formation to transfer an acetyl from acetyl-coenzyme A to glucosamine 1-phosphate to form N-acetylglucosamine 1-phosphate. Steady-state kinetic studies and equilibrium binding experiments indicate that GlmU follows a steady-state ordered kinetic mechanism, with acetyl-coenzyme A binding first, which triggers a conformational change in GlmU, followed by glucosamine 1-phosphate binding. Coenzyme A is the last product to dissociate. Chemistry is partially rate-limiting as indicated by pH-rate studies and solvent kinetic isotope effects. A novel crystal structure of a mimic of the Michaelis complex, with glucose 1-phosphate and acetyl-coenzyme A, helps us to propose the residues involved in deprotonation of glucosamine 1-phosphate and the loop movement that likely generates the active site required for glucosamine 1-phosphate to bind. Together, these results pave the way for the rational discovery of improved inhibitors against M. tuberculosis GlmU, some of which might become candidates for antibiotic discovery programs.
肽聚糖的生物合成途径对结核分枝杆菌至关重要。我们在此报告结核分枝杆菌双功能N - 乙酰转移酶/尿苷酰转移酶(GlmU)的乙酰转移酶底物特异性和催化机制。该酶负责从1 - 磷酸葡萄糖胺、乙酰辅酶A和尿苷5'-三磷酸合成UDP - N - 乙酰葡糖胺的最后两步,UDP - N - 乙酰葡糖胺是肽聚糖的必需前体。GlmU利用三元复合物的形成将乙酰基从乙酰辅酶A转移到1 - 磷酸葡萄糖胺上,形成N - 乙酰葡糖胺1 - 磷酸。稳态动力学研究和平衡结合实验表明,GlmU遵循稳态有序动力学机制,首先结合乙酰辅酶A,这会引发GlmU的构象变化,随后是1 - 磷酸葡萄糖胺结合。辅酶A是最后解离的产物。pH - 速率研究和溶剂动力学同位素效应表明,化学反应部分是限速步骤。一种模拟米氏复合物的新型晶体结构,包含1 - 磷酸葡萄糖和乙酰辅酶A,有助于我们提出参与1 - 磷酸葡萄糖胺去质子化的残基以及可能产生1 - 磷酸葡萄糖胺结合所需活性位点的环运动。总之,这些结果为合理发现针对结核分枝杆菌GlmU的改进抑制剂铺平了道路,其中一些可能成为抗生素发现计划的候选药物。